Less-toxic Drug Prolongs Survival In Metastatic Breast Cancer

A less toxic, solvent-free chemotherapy drug more effectively prevents the progression of metastatic breast cancer and has fewer side effects than a commonly used solvent-based drug. Abraxane prolonged progression-free survival by almost seven months compared with Taxotere, which is part of a class of solvent-based drugs called taxanes.

Read the whole article on Science Daily

More from Science Daily